Beth Safirstein
Neurology · Hallandale Beach, FLNPI 1851565287
Payments from drug & device makers
Across 1,692 payments — averaging $15,170 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$7.4M
- Janssen Research & Development, LLC$4.9M
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2M
- AbbVie$1.3M
- H. Lundbeck A S$1.3M
- Valneva Austria GmbH$1.2M
- plus $7.5M from 24 others
Across 19 payments — averaging $6380.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Valneva Austria GmbH$119K
- Eli Lilly$2K
- Takeda Pharmaceuticals U.S.A., Inc.$449
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 95 | $7,395,433 |
| Janssen Research & Development, LLC | 142 | $4,932,697 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 565 | $2,019,578 |
| AbbVie(2 entities) | 215 | $1,340,964 |
| H. Lundbeck A S | 47 | $1,252,808 |
| Valneva Austria GmbH | 32 | $1,182,204 |
| Modernatx, Inc. | 24 | $1,006,300 |
| Boehringer Ingelheim | 49 | $1,002,953 |
| UCB SA | 3 | $890,587 |
| Astrazeneca UK Limited | 3 | $861,425 |
| GSK | 63 | $688,843 |
| Eli Lilly | 22 | $606,408 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $528,884 |
| Takeda Pharmaceuticals U.S.A., Inc. | 79 | $480,956 |
| Pfizer | 54 | $304,238 |
| Madrigal Pharmaceuticals | 5 | $205,165 |
| Amneal Pharmaceuticals LLC | 31 | $163,753 |
| Novavax Inc | 13 | $134,512 |
| Biogen | 2 | $117,650 |
| Teva Pharmaceuticals USA, Inc. | 32 | $113,605 |
| E.r. Squibb & Sons, L.L.C. | 7 | $102,712 |
| Acorda Therapeutics, Inc | 8 | $88,274 |
| Jazz Pharmaceuticals Inc. | 4 | $51,483 |
| Ipsen Innovation | 60 | $45,818 |
| Genentech, Inc. | 7 | $41,682 |
| Avanir Pharmaceuticals, Inc. | 8 | $30,751 |
| Eisai Inc. | 6 | $26,282 |
| Boehringer Ingelheim International GmbH | 100 | $25,782 |
| Sanofi Pasteur Inc. | 5 | $24,435 |
| Boehringer Ingelheim RCV GmbH & Co KG | 3 | $1,165 |
How this compares
$25,667,348 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.
Other neurology in Hallandale Beach
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
- Rekha GandhiWinter Park$13.4M
- Sheila Baez-TorresWinter Park$12.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.